These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Antinociception induced by 3-((+-)-2-carboxypiperazin-4-yl)-propyl-1- phosphonic acid (CPP), an N-methyl-D-aspartate (NMDA) competitive antagonist, plus 6,7-dinitroquinoxaline-2,3-dione (DNQX), a non-NMDA antagonist, differs from that induced by MK-801 plus DNQX. Goettl VM; Larson AA Brain Res; 1994 Apr; 642(1-2):334-8. PubMed ID: 8032897 [TBL] [Abstract][Full Text] [Related]
12. The competitive NMDA antagonist, D-CPP-ene, potentiates the anticonvulsant activity of conventional antiepileptics against maximal electroshock-induced seizures in mice. Zarnowski T; Kleinrok Z; Turski WA; Czuczwar SJ Neuropharmacology; 1994 May; 33(5):619-24. PubMed ID: 7936096 [TBL] [Abstract][Full Text] [Related]
13. Gamma-aminobutyric acid and the high pressure neurological syndrome. Rostain JC; Wardley-Smith B; Forni C; Halsey MJ Neuropharmacology; 1986 May; 25(5):545-54. PubMed ID: 3090469 [TBL] [Abstract][Full Text] [Related]
14. Agmatine induces antihyperalgesic effects in diabetic rats and a superadditive interaction with R(-)-3-(2-carboxypiperazine-4-yl)-propyl-1-phosphonic acid, a N-methyl-D-aspartate-receptor antagonist. Courteix C; Privat AM; Pélissier T; Hernandez A; Eschalier A; Fialip J J Pharmacol Exp Ther; 2007 Sep; 322(3):1237-45. PubMed ID: 17551093 [TBL] [Abstract][Full Text] [Related]
15. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo. Lehmann J; Schneider J; McPherson S; Murphy DE; Bernard P; Tsai C; Bennett DA; Pastor G; Steel DJ; Boehm C J Pharmacol Exp Ther; 1987 Mar; 240(3):737-46. PubMed ID: 2882014 [TBL] [Abstract][Full Text] [Related]
16. Topographic electroencephalographic studies in a hyperbaric environment--specific reference to high pressure nervous syndrome. Okuda S; Matsuoka S; Mohri M J UOEH; 1988 Sep; 10(3):247-61. PubMed ID: 3175383 [TBL] [Abstract][Full Text] [Related]
17. Effect of cerebral hypoxia on NMDA receptor binding characteristics after treatment with 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) in newborn piglets. Fritz KI; Groenendaal F; McGowan JE; Mishra OP; Delivoria-Papadopoulos M Brain Res; 1996 Aug; 729(1):66-74. PubMed ID: 8874877 [TBL] [Abstract][Full Text] [Related]
18. Modulation of isolated N-methyl-d-aspartate receptor response under hyperbaric conditions. Mor A; Grossman Y Eur J Neurosci; 2006 Dec; 24(12):3453-62. PubMed ID: 17229094 [TBL] [Abstract][Full Text] [Related]
19. CPP, an NMDA-receptor antagonist, blocks 4-aminopyridine-induced spreading depression episodes but not epileptiform activity in immature rat hippocampal slices. Psarropoulou C; Avoli M Neurosci Lett; 1992 Jan; 135(1):139-43. PubMed ID: 1347414 [TBL] [Abstract][Full Text] [Related]
20. Competitive NMDA receptor antagonists attenuate phencyclidine-induced excitations of A10 dopamine neurons. French ED Eur J Pharmacol; 1992 Jun; 217(1):1-7. PubMed ID: 1397021 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]